136 related articles for article (PubMed ID: 9409365)
1. Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages.
Kerr SJ; Armati PJ; Pemberton LA; Smythe G; Tattam B; Brew BJ
Neurology; 1997 Dec; 49(6):1671-81. PubMed ID: 9409365
[TBL] [Abstract][Full Text] [Related]
2. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
3. Quinolinic acid production is related to macrophage tropic isolates of HIV-1.
Brew BJ; Corbeil J; Pemberton L; Evans L; Saito K; Penny R; Cooper DA; Heyes MP
J Neurovirol; 1995 Dec; 1(5-6):369-74. PubMed ID: 9222379
[TBL] [Abstract][Full Text] [Related]
4. Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection.
Guillemin GJ; Kerr SJ; Smythe GA; Smith DG; Kapoor V; Armati PJ; Croitoru J; Brew BJ
J Neurochem; 2001 Aug; 78(4):842-53. PubMed ID: 11520905
[TBL] [Abstract][Full Text] [Related]
5. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
6. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.
Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP
J Neuroimmunol; 1992 Sep; 40(1):71-80. PubMed ID: 1387655
[TBL] [Abstract][Full Text] [Related]
7. The regulation of quinolinic acid in human immunodeficiency virus-infected monocytes.
Nottet HS; Flanagan EM; Flanagan CR; Gelbard HA; Gendelman HE; Reinhard JF
J Neurovirol; 1996 Apr; 2(2):111-7. PubMed ID: 8799202
[TBL] [Abstract][Full Text] [Related]
8. [Biochemical studies on AIDS dementia complex--possible contribution of quinolinic acid during brain damage].
Saito K
Rinsho Byori; 1995 Sep; 43(9):891-901. PubMed ID: 7474452
[TBL] [Abstract][Full Text] [Related]
9. Increased quinolinate immunoreactivity in the peripheral blood monocytes/macrophages from SIV-infected monkeys.
Namboodiri AM; Venkateshan CN; Narayanan R; Blinder K; Moffett JR; Gajdusek DC; Gravell M; Gibbs CJ
J Neurovirol; 1996 Dec; 2(6):433-8. PubMed ID: 8972426
[TBL] [Abstract][Full Text] [Related]
10. 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).
Saito K; Chen CY; Masana M; Crowley JS; Markey SP; Heyes MP
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):11-4. PubMed ID: 8471029
[TBL] [Abstract][Full Text] [Related]
11. Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques.
Heyes MP; Saito K; Lackner A; Wiley CA; Achim CL; Markey SP
FASEB J; 1998 Jul; 12(10):881-96. PubMed ID: 9657528
[TBL] [Abstract][Full Text] [Related]
12. Human microglia convert l-tryptophan into the neurotoxin quinolinic acid.
Heyes MP; Achim CL; Wiley CA; Major EO; Saito K; Markey SP
Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):595-7. PubMed ID: 8973572
[TBL] [Abstract][Full Text] [Related]
13. Neurocytotoxity of quinolinic acid in human brain cultures.
Kerr SJ; Armati PJ; Brew BJ
J Neurovirol; 1995 Dec; 1(5-6):375-80. PubMed ID: 9222380
[TBL] [Abstract][Full Text] [Related]
14. 6-Chloro-D,L-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation.
Saito K; Markey SP; Heyes MP
Neurosci Lett; 1994 Sep; 178(2):211-5. PubMed ID: 7824198
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical localization of the endogenous neuroexcitotoxin quinolinate in human peripheral blood monocytes/macrophages and the effect of human T-cell lymphotropic virus type I infection.
Venkateshan CN; Narayanan R; Espey MG; Moffett JR; Gajdusek DC; Gibbs CJ; Namboodiri MA
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1636-41. PubMed ID: 8643683
[TBL] [Abstract][Full Text] [Related]
16. Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD
Moffett JR; Arun P; Puthillathu N; Vengilote R; Ives JA; Badawy AA; Namboodiri AM
Front Immunol; 2020; 11():31. PubMed ID: 32153556
[TBL] [Abstract][Full Text] [Related]
17. Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons.
Guillemin GJ; Smythe G; Takikawa O; Brew BJ
Glia; 2005 Jan; 49(1):15-23. PubMed ID: 15390107
[TBL] [Abstract][Full Text] [Related]
18. Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types.
Heyes MP; Chen CY; Major EO; Saito K
Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):351-6. PubMed ID: 9291104
[TBL] [Abstract][Full Text] [Related]
19. Expression of the kynurenine pathway enzymes in human microglia and macrophages.
Guillemin GJ; Smith DG; Smythe GA; Armati PJ; Brew BJ
Adv Exp Med Biol; 2003; 527():105-12. PubMed ID: 15206722
[TBL] [Abstract][Full Text] [Related]
20. Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat.
Smith DG; Guillemin GJ; Pemberton L; Kerr S; Nath A; Smythe GA; Brew BJ
J Neurovirol; 2001 Feb; 7(1):56-60. PubMed ID: 11519483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
